Russell Investments Group, Ltd. - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 100 filers reported holding RAPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.4%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,656
-54.1%
581
-48.3%
0.00%
Q2 2023$21,018
+1.9%
1,1240.0%0.00%
Q1 2023$20,625
+91.8%
1,124
+107.0%
0.00%
Q4 2022$10,751
-17.3%
5430.0%0.00%
Q3 2022$13,000
-96.0%
543
-94.6%
0.00%
-100.0%
Q3 2020$325,00010,1000.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Ponoi Management, LLC 1,599,417$35,171,00045.66%
KPCB XV Associates, LLC 1,297,063$28,522,00036.91%
Ponoi II Management, LLC 145,401$3,197,0007.10%
Column Group LLC 1,402,008$30,830,0005.72%
Euclidean Capital LLC 432,900$9,519,0005.53%
AJU IB Investment Co., Ltd. 99,503$2,188,0003.38%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,088,321$23,932,0002.49%
Velan Capital Investment Management LP 110,000$2,419,0002.24%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 443,619$9,755,0001.46%
Perceptive Advisors 2,799,962$61,571,0001.23%
View complete list of RAPT THERAPEUTICS INC shareholders